title: [Perceived health status and pharmacological adherence of patients who underwent percutaneous coronary intervention].
abstract: The objectives of this study were to evaluate the perceived health status and pharmacological adherence, and to verify the correlation between these measures in patients who underwent percutaneous coronary intervention, after hospital discharge. It was a cross-sectional study carried out from May 2011 to July 2012. The instruments used were: SF-86 and Measurement of Adherence to Treatment, with 101 patients, 54 (53.5%) of which were men; average age of 59.5 +/- 10.3; and 32 (32.7%) with previous cardiac treatment. All study participants were using antihypertensive drugs; the majority 99 (98%) used antiplatelet drugs; 98 (97%) used cholesterol reducers, and 59 (58.4%) used coronary vasodilators. The average number of drugs used was 6.8 +/- 2.1. Pharmacological adherence was observed in 98 (97%) patients. The participants presented best perceived health status in Social Functioning and Physical Functioning. Positive correlations of moderate magnitude were found between measurements of pharmacological adherence and Physical Functioning, General Health and Social Functioning. There was correlation between pharmacological adherence and perceived health status.
authors.forename: Mariana
authors.initials: M
authors.lastname: Coelho
authors.affiliation: EERP-USP, Ribeirilo Preto, SP, Brasil.
authors.forename: Eliana de Cássia Arantes
authors.initials: Ede C
authors.lastname: Costa
authors.affiliation: EERP-USP, Ribeirlo Preto, SP, Brasil.
authors.forename: Vitor César
authors.initials: VC
authors.lastname: Richter
authors.affiliation: EERP-USP, Ribeirlo Preto, SP, Brasil.
authors.forename: Carina Aparecida Marosti
authors.initials: CA
authors.lastname: Dessotte
authors.affiliation: School of Medicine, University of Washington, Seattle, Washington, Estados Unidos.
authors.forename: Marcia Aparecida
authors.initials: MA
authors.lastname: Ciol
authors.affiliation: Faculdade de Medicina de Ribeirão Preto da Universidade de Sio Paulo, Ribeirlo Preto, SP, Brasil.
authors.forename: André
authors.initials: A
authors.lastname: Schmidt
authors.affiliation: EERP-USP, Ribeirlo Preto, SP, Brasil.
authors.forename: Rosana Aparecida Spadoti
authors.initials: RA
authors.lastname: Dantas
authors.affiliation: EERP-USP, Ribeirlo Preto, SP, Brasil.
authors.forename: Lídia Aparecida
authors.initials: LA
authors.lastname: Rossi
authors.affiliation: Escola de Enfermagem de Ribeirão Preto da Universidade de Sio Paulo, Ribeirilo Preto, SP, Brasil.
authors.forename: Rejane Kiyomi
authors.initials: RK
authors.lastname: Furuya
mesh_terms: D000359:Aftercare; D000368:Aged; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015897:Comorbidity; D003430:Cross-Sectional Studies; D004359:Drug Therapy, Combination; D004644:Emotions; D005260:Female; D006304:Health Status; D006801:Humans; D008297:Male; D008875:Middle Aged; D010342:Patient Acceptance of Health Care; D010361:Patients / Q000523:psychology*; D062645:Percutaneous Coronary Intervention / Q000451:nursing / Q000523:psychology / Q000706:statistics & numerical data; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011788:Quality of Life; D012649:Self Concept; D012917:Social Adjustment; D015607:Stents / Q000523:psychology; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016903:Drug Monitoring
chemical_list: D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents